|| | | | | |

Association of mutation to drug resistance

Mutation Gene Species Validation status Validation technique(s) Validation reference(s) Resistance mechanism(s) Validation score
A643V UPC2 C. albicans Validated Site-directed mutagenesis, qRT-PCR22923048
25385095
28461316
A643V mutation in UPC2 enhances ERG11 and MDR1 expression, increasing ergosterol synthesis and drug efflux, leading to azole resistance. 2